Natalya Semenova | Medicine and Health Sciences | Women Researcher Award

Published on by Research Hypothesis

Dr. Natalya Semenova | Medicine and Health Sciences | Women Researcher Award

Dr. Natalya Semenova | Medicine and Health Sciences | Chief Researcher at Scientific Сentre for Family Health and Human Reproduction Problem | Russia 

Dr. Natalya Semenova is a highly accomplished female biomedical scientist and chief researcher recognized for her significant contributions to pathological physiology, reproductive health, and aging research. She holds a Ph.D. in Biological Sciences and has developed a strong academic foundation through advanced training in experimental biology, human reproduction, and translational medical science at leading scientific institutions. Dr. Natalya Semenova has built an extensive professional career at a federal-level public scientific research center, where she has led and contributed to numerous multidisciplinary research initiatives focused on women’s health, endocrine disorders, microbiome regulation, oxidative stress, and age-related diseases. Her professional experience reflects deep expertise in designing experimental studies, clinical-biological data interpretation, biomarker analysis, and the development of pathogenetically grounded therapeutic and preventive strategies. In the middle of her academic career profile, Dr. Natalya Semenova has authored 156 documents, received 685 citations, and achieved a 12 h-index, demonstrating consistent research productivity and measurable scholarly impact within the international scientific community.

Citation Metrics (Scopus)

1000

800

600

400

200

0

Citations
685

Documents
156

h-index
12

🟦 Citations     🟥 Documents    🟩 h-index

View Scopus Profile

Featured Publications

Optimal Algorithm for Gut Microbiota Differentiation: A Pilot Study of Adolescents with Different Body Weights
– Frontiers in Bioscience (Scholar Edition)
Phosphatidylethanol 16:0/18:1PEth as a Biomarker of Alcohol Consumption during Pregnancy
– Bulletin of Experimental Biology and Medicine
Histostructure of the Hippocampus in Male and Female Wistar Rats with Diet-Induced Visceral Obesity and after Diet Correction
– Bulletin of Experimental Biology and Medicine
Pregnancy and Alcohol: Parameters of Endogenous Intoxication Depending on Blood Phosphatidylethanol Levels
– Human Ecology
Comparative Assessment of the Gut Microbiome by Microbiological and Molecular-Genetic Methods in Sleep Disorders
– Clinical Laboratory Diagnostics

Ping Yuan | Medicine and Health Sciences | Research Excellence Award

Published on by Research Hypothesis

Prof Ping Yuan | Medicine and Health Sciences | Research Excellence Award

Prof Ping Yuan | Medicine and Health Sciences | Research Excellence Award | Principle Investigator | The Sixth Affiliated Hospital, Sun Yat-sen University | China 

Prof. Ping Yuan is a distinguished researcher and professor currently serving as Principal Investigator at the Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University (since January 2017), with prior appointments including Assistant Professor at the Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong (2010–2016); Postdoctoral Fellow (Stem Cell) at the Genome Institute of Singapore (2006–2010); Research Associate in Molecular Biology at Princeton University (2004–2006); and Visiting Research Fellow in Pathology at Brigham and Women’s Hospital, Boston (2001). He earned his Ph.D. from the Institute of Molecular and Cell Biology, National University of Singapore (completed 2004), after completing an M.S. in Microbiology at the Wuhan Institute of Virology, Chinese Academy of Sciences, and a B.S. from the School of Biological Sciences, Central China Normal University. Over his career, Prof. Ping Yuan has secured multiple competitive research grants — including support from the National Natural Science Foundation of China for work on YAP-associated super-enhancers in stem cells (Grant 31970674, 2020–2023), inhibition of glioblastoma stem cell proliferation (Grant 8177110391, 2018–2021), and the role of DNA repair factor Rif1 in teratocarcinoma formation (Grant 81372162, 2014–2017), as well as funding from the Research Grants Council of Hong Kong for building an in-vitro system to reconstitute female germ-lineage cells (Grant 479512, 2013–2016). His research interests center on cancer stem cells, pluripotent stem cells, epigenetic modification, and single-cell RNA sequencing (scRNA-seq), with research skills spanning molecular biology, stem cell biology, epigenetics, in vitro and in vivo functional assays, bioinformatics and genomics. Prof. Ping Yuan has contributed significantly to our understanding of how pathways such as Hippo-YAP regulate stem cell differentiation and how dysregulation may underlie cancer, particularly colorectal and other cancers. His recent work includes demonstration that interference with CAPG induces apoptosis and ferroptosis via the p53 pathway in colorectal cancer cells, and that UCKL1 plays a non-canonical role in ferroptosis defense in colorectal cancer, highlighting potential therapeutic targets. Through his sustained funding, leadership roles, and prolific output, Prof. Ping Yuan has established himself as a leading figure in the intersection of stem cell biology, epigenetics, and cancer research, influencing both basic stem cell science and translational oncology.

Profile:  scopus | ORCID 

Featured Publications

  1. CAPG interference induces apoptosis and ferroptosis in colorectal cancer cells through the P53 pathway. (2023). Molecular and Cellular Probes.

  2. Non-canonical role of UCKL1 on ferroptosis defence in colorectal cancer. (2023). EBioMedicine.

  3. Silence of a dependence receptor CSF1R in colorectal cancer cells activates tumor-associated macrophages. (2022). Journal for Immunotherapy of Cancer.

  4. Lin28 inhibits the differentiation from mouse embryonic stem cells to glial lineage cells through upregulation of Yap1. (2021). Stem Cells International.

  5. Hippo-YAP signaling controls lineage differentiation of mouse embryonic stem cells through modulating the formation of super-enhancers. (2020). Nucleic Acids Research, 48(13), 7182–7196.

  6. CFTR constrains the differentiation from mouse embryonic stem cells to intestine lineage cells. (2019). Biochemical and Biophysical Research Communications.

  7. Differentiation of female Oct4-GFP embryonic stem cells into germ lineage cells. (2018). Cell Biology International

Qianheng Jin | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Dr. Qianheng Jin | Medicine and Health Sciences | Best Researcher Award

Dr. Qianheng Jin | Medicine and Health Sciences | Attending physician | Suzhou Ruihua Orthopedic Hospital | China

Dr. Qianheng Jin is a highly accomplished physician and researcher whose work bridges clinical orthopedics and regenerative medicine. With a career rooted in advancing patient care, he has combined surgical expertise with pioneering biomedical research, focusing on innovative approaches in tissue engineering, wound healing, and bioprinting. His professional journey highlights a consistent commitment to improving treatment outcomes, particularly in complex reconstructive procedures and vascularized tissue regeneration. Dr. Qianheng Jin is recognized for integrating advanced research into clinical practice, making significant contributions to both academic science and applied medical solutions that directly benefit patients.

Professional Profile 

Education

Dr. Qianheng Jin pursued his advanced medical and doctoral studies at Soochow University, where he specialized in the fields of orthopedic surgery, regenerative medicine, and biomedical engineering. His academic training emphasized translational research, with a focus on developing engineered tissues and vascularized constructs capable of improving clinical outcomes in reconstructive surgery. Through rigorous education and extensive research engagement, Dr. Qianheng Jin has cultivated deep expertise in surgical techniques, tissue biology, and biomaterial applications, which now form the foundation of his academic and clinical contributions.

Experience

Dr. Qianheng Jin serves as a physician at Suzhou Ruihua Orthopedic Hospital, where he applies his knowledge in treating complex injuries and performing advanced replantation surgeries. His professional experience is characterized by a balance between hands-on surgical practice and groundbreaking laboratory-based innovations. In his role, he has contributed to the establishment of emergency protocols for major limb replantation, leading to significant improvements in patient outcomes. Beyond clinical service, he has actively participated in collaborative research projects that link medical institutions and international academic communities. This blend of professional experience underscores his ability to merge theory and practice while fostering a collaborative research culture.

Research Interest

The research interests of Dr. Qianheng Jin lie in the intersection of regenerative medicine, bioprinting technologies, and clinical orthopedics. His work particularly focuses on the development of engineered dermal tissues, small-diameter vascular grafts, and advanced wound healing strategies. He has contributed to the exploration of bioprinted vascularized constructs that mimic natural tissue structures and improve graft survival. Additionally, his studies extend to investigating molecular mechanisms that influence tissue repair and regeneration, offering valuable insights into translational applications. Dr. Qianheng Jin work demonstrates his dedication to advancing clinical solutions through innovative biomedical technologies that address unmet challenges in reconstructive medicine.

Award

Dr. Qianheng Jin has been recognized for his contributions through academic excellence, impactful research, and clinical innovation. His published works in highly respected journals highlight his role as a thought leader in regenerative medicine and bioprinting. These achievements underscore his eligibility for awards that honor research excellence, clinical impact, and international collaboration. His record reflects not only scholarly productivity but also the translation of research into practical applications, affirming his status as a deserving candidate for this nomination.

Selected Publication

  • A multidisciplinary emergency protocol reduces revascularization time in major upper and lower limb replantations (2025) – 18 Citations

  • Bioprinted dermis with human adipose tissue‐derived microvascular fragments promotes wound healing (2024) – 32 Citations

  • Engineered dermis loaded with confining forces promotes full-thickness wound healing by enhancing vascularisation and epithelialisation (2023) – 27 Citations

  • Bioprinting small diameter blood vessel constructs with an endothelial and smooth muscle cell bilayer in a single step (2020) – 41 Citations

Conclusion

Dr. Qianheng Jin exemplifies the qualities of an outstanding clinician-researcher whose dedication to advancing science and medicine has resulted in significant contributions to orthopedic surgery, regenerative medicine, and biomedical engineering. His career reflects a rare balance between direct patient care and innovative research, producing outcomes that resonate within both clinical practice and global academic discourse. With a growing body of high-impact publications, international collaborations, and leadership in clinical innovation, Dr. Qianheng Jin continues to pave the way for advancements in reconstructive medicine. His achievements, professional dedication, and potential for future breakthroughs make him an exceptional candidate for this award nomination, representing both scientific excellence and meaningful societal contribution.